Account

Sign in to access your account and subscription

Legislative Solutions to Toxic Torts: Congress and the Thimerosal and Asbestos Litigations

It has been estimated that at least 600,000 people have brought asbestos-related personal injury suits. Typically, each plaintiff sues dozens of defendants, so the total volume of litigation has reached nearly astronomical proportions. The total amount spent on asbestos litigation (awards and expenses) to date is staggering and has been estimated to be on the order of $54 billion. Many critics have said that this litigation has been abused, leading to the enrichment of plaintiff lawyers at the expense of those actually injured by asbestos exposure. According to one study, only about 43% of total spending has reached the claimants as their net recovery. <i>See</i> Stephen Carroll, <i>et al</i>., <i>Asbestos Litigation Costs and Compensation: An Interim Report,</i> RAND Institute for Civil Justice, Santa Monica, Calif. (Sept. 2002). The RAND report is available at <i>www.rand.org/publications/DB/DB397.</i>

26 minute read June 28, 2004 at 09:45 AM
By
Roger K. Smith, Ph.D.
Legislative Solutions to Toxic Torts: Congress and the Thimerosal and Asbestos Litigations

Part Two of a Two-Part Series

Part One of this article described the litigation and legislation surrounding thimerosal. The conclusion addresses asbestos litigation and the legislative response.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

The combination of increasing operating costs and uncertain government reimbursement funding continues to place health care providers under financial pressure, and in many cases, financial distress. Given the importance of Medicare/Medicaid funding of claims under provider agreements with the federal government, how courts interpret and apply the interplay between the Bankruptcy Code and Medicare Program Act determines the disposition of hundreds of millions of dollars of claims for reimbursement that support the health care system.

April 30, 2026

As AI becomes embedded in everyday business and legal operations, organizations are confronting a new expectation: simply disclosing AI use is no longer enough. A critical shift is taking place in the legal industry: transparency is no longer just about disclosure; it’s about comprehension.

April 30, 2026